News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
5 articles suggested by Wafik El-Deiry
Jan 27, 2025, 04:40

5 articles suggested by Wafik El-Deiry

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.

Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.

Wafik El-Deiry

Wafik El-Deiry shared a few must-reads paper on X:

Predisposition Footprints in the Somatic Genome of Wilms Tumors

Authors: Taryn D. Treger et al.

5 articles suggested by Wafik El-Deiry

Artificial intelligence propels lung cancer screening: innovations and the challenges of explainability and reproducibility

Authors: Mario Mascalchi et al.

5 articles suggested by Wafik El-Deiry

Chemical catalyst manipulating cancer epigenome and transcription

Authors: Yuki Yamanashi et al.

5 articles suggested by Wafik El-Deiry

Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migration

Authors: Fang Cheng Wong et al.

5 articles suggested by Wafik El-Deiry

Immune evasion through mitochondrial transfer in the tumour microenvironment

Authors: Hideki Ikeda et al.

5 articles suggested by Wafik El-Deiry

Adrian M. Seifert Akiko Honobe-Tabuchi Aleksandra Letunovska Ana Mansourkiaei Angus Hodder Anna Wenger Atsushi Iwama Atsushi Kaneda Atsushi Okabe Barbara Ziegler Bianca F. Goemans Bo Kong cancer Carina Wenzel Chiara Marzi Christian Sperling Christian Vokuhl Christoph Kahlert Conor Parks Daniela E. Aust Dirk Reinhardt Eiki Ichihara Eline J.M. Bertrums Evangelia Antoniou Fang Cheng Wong Farzaneh Malekian Gordan M. Vujanic Guillaume Morcrette Gustavo Baretton Heike Polster Heike Streitenberger Henry Lee-Six Hideki Ikeda Hideki Makinoshima Hidetoshi Hayashi Hiroyuki Mano Hitoshi Kurumizaka Hyunchul Jung Ihsan Ekin Demir Jack Bartram Jarno Drost Jason Lin Jenny Wegert John C. Hutchinson Joji Nagasaki Jonathan Kennedy Jun-ichiro Ikeda Jürgen Weitz Kathy Pritchard-Jones Katsushige Kawase Keizo Takenaga Kenzo Yamatsugu Lena Seifert Linhan Ye Lisa Bauer Lukas Böthig Makiko Itami Manfred Gessler Mario Mascalchi Marry M. van den Heuvel-Eibrink Masahito Kawazu Mathieu Pecqueux Max Heiduk Mi K. Trinh Motomu Kanai Nathaniel D. Anderson Norbert Graf OncoDaily Oncology Pascal Drobisch Paul G. Kemps Reem Al-Saadi Rhoikos Furtwängler Rouzanna Istvanffy Ruben van Boxtel Sam Behjati Satoshi Kaito Sebastian R. Merker Shigehiro A. Kawashima Shinichi Toyooka Shinichiro Suzuki Shinpei Takamaru Sho Aki Shusuke Kawashima Stefano Diciotti Takamasa Ishino Takao Morinaga Takashi Inozume Takehiro Ohnuma Takuji Suzuki Tanzina Chowdhury Taryn D. Treger Tatsuya Nishi Tatsuyoshi Kawamura Tim H.H. Coorens Tomofumi Watanabe Tomoya Kujirai Toochi Ogbonnah Toyoyuki Hanazawa Tsuyoshi Osawa Van Manh Hung Le Venkatesh Sadananda Rao Wafik El-Deiry Yasuhiro Nakamura Yasutoshi Tatsumi Yi Han Yoshiyasu Umeda Yosuke Togashi Youki Ueda Yugo R. Kamimura Yuki Nakamura Yuki Yamanashi Yukiko Kiniwa Yusuke Suenaga Yuto Azumaya
Special Coverage
Opinion
Jan 27, 2025, 04:40
5 articles suggested by Wafik El-Deiry
Science
Jan 26, 2025, 21:58
Nikolas Naleid: Excited to share our systematic review on pembrolizumab safety in GI cancers
Science
Jan 26, 2025, 21:58
David J. Benjamin: Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma?
Science
Jan 26, 2025, 21:58
Fumiko Ladd Chino: Developing a simplified financial toxicity screening tool for use in clinical practice
Blog
Jan 26, 2025, 21:56
Wafaa M Rashed: Developing localized guidelines that reflect the continent's cultural, social and economic contexts
Blog
Jan 26, 2025, 21:56
Supriya Peshin: The most extraordinary team in GI oncology
Blog
Jan 26, 2025, 21:55
Razelle Kurzrock: Target Cancer National Molecular Tumor Board
Blog
Jan 26, 2025, 21:55
The current status of BCG and ways to accommodate the shortage
Blog
Jan 26, 2025, 21:55
Adjuvant chemotherapy vs Adjuvant CTRT in Gallbladder cancer
Blog
Jan 26, 2025, 21:55
Antonio D'Alessio: 9 year follow-up of adjuvant cell therapy for HCC at ASCOGI25
Blog
Jan 26, 2025, 17:30
Pan-RAS Inhibitor Shows Early, Deep Molecular Responses in PDAC
Blog
Jan 26, 2025, 17:23
Trisha Lal: Day 1 of ASCOGI25